FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease5/11/23, 12:00 AMThe U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...
Treatment-Resistant Depression Associated With High Mortality, Lost Work Days, Health Care Use12/21/22, 12:00 AM
